Terminal riboadenylate transferase in human lymphocytes.
D000166:Acridines / Q000494:pharmacology; D002467:Cell Nucleus / Q000201:enzymology; D002499:Centrifugation, Density Gradient; D003593:Cytoplasm / Q000201:enzymology; D004254:DNA Nucleotidyltransferases / Q000032:analysis / Q000378:metabolism; D003609:Dactinomycin / Q000494:pharmacology; D003959:Diamines / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000166:cytology / Q000201:enzymology*; D008938:Mitosis; D009183:Mycotoxins / Q000494:pharmacology; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012293:Rifampin / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000166:Acridines; D003959:Diamines; D037102:Lectins; D009183:Mycotoxins; D014316:Tritium; D003609:Dactinomycin; D004254:DNA Nucleotidyltransferases; D012316:RNA Nucleotidyltransferases; D005033:Ethylmaleimide; D013936:Thymidine; D012293:Rifampin